Login / Signup

Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.

Arpita ChakravartiGuillaume Butler-LaporteFrançois-Martin CarrierMarc BilodeauGenevieve HuardDaniel CorsilliPatrice SavardMe-Linh Luong
Published in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
Targeted caspofungin prophylaxis was associated with lower rate of IA.
Keyphrases
  • cancer therapy
  • drug delivery